Planning Capital Management Corporation’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Planning Capital Management Corporation's LLY Position: Q3 2024 in Review
Planning Capital Management Corporation reduced its Eli Lilly (LLY) stake by 70% in Q3 2024, selling an estimated $236K and leaving 112 shares worth $99.2K. The position accounts for 0.07% of the portfolio, ranked #134.
Planning Capital Management Corporation first reported a position in LLY in Q4 2023 and has held it in 4 quarters since. The position peaked at $340K in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Planning Capital Management Corporation held 112 shares of Eli Lilly worth $99.2K as of Q3 2024.
- Planning Capital Management Corporation sold 263 Eli Lilly shares in Q3 2024, an estimated $236K.
- Eli Lilly made up 0.07% of Planning Capital Management Corporation's portfolio in Q3 2024, its #134 holding.
- Planning Capital Management Corporation first reported a position in Eli Lilly in Q4 2023 and has held it in 4 quarters since.
- Planning Capital Management Corporation's Eli Lilly position peaked at $340K in Q2 2024.
- 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.